过敏性肺炎相关死亡率的多国趋势分析:32国1999-2019年数据
Temporal trends in hypersensitivity pneumonitis–coded mortality: a multinational analysis of 32 countries, 1999–2019
32国1999-2019年过敏性肺炎相关死亡率分析显示,死亡率在2004年后年均增长7.34%(95% CI 6.66-8.02),整体年均增幅达5.43%(95% CI 4.35-6.52)。
- Article
- Open access
- Published: 26 October 2026
Scientific Reports (2026) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Abstract
Contemporary evidence on hypersensitivity pneumonitis (HP) mortality trends remains limited. Using World Health Organization Mortality Database data (ICD-10: J67) from 32 countries, we analyzed 7,581 deaths in adults aged ≥ 20 years between 1999 and 2019. Age-standardized mortality rates (ASMRs) were calculated using the WHO World Standard Population; joinpoint regression estimated annual and average annual percent changes (APC, AAPC), and Kitagawa decomposition separated the contributions of population age structure and age-specific mortality rates. The pooled ASMR was 0.0394 per 100,000 (95% CI 0.0385–0.0403). HP-coded mortality was stable from 1999 to 2004 and rose thereafter (APC 7.34%; 95% CI 6.66–8.02), giving an AAPC of 5.43% (95% CI 4.35–6.52). HP-coded mortality was higher in men (0.0496 versus 0.0317 per 100,000), increased more steeply in women (AAPC 6.40% versus 4.45%) and rose with age to 0.2977 per 100,000 at ≥ 80 years. Among the 25 countries with ≥ 30 deaths, eight showed a significant increase and two a significant decrease. Population aging accounted for 12.2% of the increase in crude mortality among adults aged ≥ 40 years. HP-coded mortality increased across this multinational sample with substantial between-country heterogeneity, which may reflect changes in diagnostic recognition and certification practice as well as in disease occurrence.
Funding
This study was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: RS-2025-25459103), by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (RS-2025-23523012), and the Soonchunhyang University Research Fund.
Author information
Authors and Affiliations
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul, 04401, Republic of Korea
Hee-Young Yoon
Authors
- Hee-Young Yoon
Corresponding author
Correspondence to Hee-Young Yoon.
Ethics declarations
Competing interests
The author declares no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Yoon, HY. Temporal trends in hypersensitivity pneumonitis–coded mortality: a multinational analysis of 32 countries, 1999–2019. Sci Rep (2026). https://doi.org/10.1038/s41598-026-78178-x
Received: 08 August 2026
Accepted: 23 October 2026
Published: 26 October 2026
DOI: https://doi.org/10.1038/s41598-026-78178-x
Keywords
来源:Nature 健康护理主题 · nature.com